These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 12810654)
1. Geldanamycin and its 17-allylamino-17-demethoxy analogue antagonize the action of Cisplatin in human colon adenocarcinoma cells: differential caspase activation as a basis for interaction. Vasilevskaya IA; Rakitina TV; O'Dwyer PJ Cancer Res; 2003 Jun; 63(12):3241-6. PubMed ID: 12810654 [TBL] [Abstract][Full Text] [Related]
2. Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines. Vasilevskaya IA; Rakitina TV; O'Dwyer PJ Mol Pharmacol; 2004 Jan; 65(1):235-43. PubMed ID: 14722256 [TBL] [Abstract][Full Text] [Related]
3. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity. Bisht KS; Bradbury CM; Mattson D; Kaushal A; Sowers A; Markovina S; Ortiz KL; Sieck LK; Isaacs JS; Brechbiel MW; Mitchell JB; Neckers LM; Gius D Cancer Res; 2003 Dec; 63(24):8984-95. PubMed ID: 14695217 [TBL] [Abstract][Full Text] [Related]
4. Effects of geldanamycin on signaling through activator-protein 1 in hypoxic HT29 human colon adenocarcinoma cells. Vasilevskaya IA; O'Dwyer PJ Cancer Res; 1999 Aug; 59(16):3935-40. PubMed ID: 10463587 [TBL] [Abstract][Full Text] [Related]
5. Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts. Nimmanapalli R; O'Bryan E; Bhalla K Cancer Res; 2001 Mar; 61(5):1799-804. PubMed ID: 11280726 [TBL] [Abstract][Full Text] [Related]
6. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin. Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458 [TBL] [Abstract][Full Text] [Related]
8. Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor kappaB signaling. Rakitina TV; Vasilevskaya IA; O'Dwyer PJ Cancer Res; 2003 Dec; 63(24):8600-5. PubMed ID: 14695170 [TBL] [Abstract][Full Text] [Related]
9. Geldanamycin and its analog induce cytotoxicity in cultured human retinal pigment epithelial cells. Wu WC; Wu MH; Chang YC; Hsieh MC; Wu HJ; Cheng KC; Lai YH; Kao YH Exp Eye Res; 2010 Aug; 91(2):211-9. PubMed ID: 20493187 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models. Smith V; Sausville EA; Camalier RF; Fiebig HH; Burger AM Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378 [TBL] [Abstract][Full Text] [Related]
11. Coadministration of the heat shock protein 90 antagonist 17-allylamino- 17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells. Rahmani M; Yu C; Dai Y; Reese E; Ahmed W; Dent P; Grant S Cancer Res; 2003 Dec; 63(23):8420-7. PubMed ID: 14679005 [TBL] [Abstract][Full Text] [Related]
12. Erybraedin C and bitucarpin A, two structurally related pterocarpans purified from Bituminaria bituminosa, induced apoptosis in human colon adenocarcinoma cell lines MMR- and p53-proficient and -deficient in a dose-, time-, and structure-dependent fashion. Maurich T; Iorio M; Chimenti D; Turchi G Chem Biol Interact; 2006 Feb; 159(2):104-16. PubMed ID: 16271357 [TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin. Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155 [TBL] [Abstract][Full Text] [Related]
14. Degradation of HER2 by ansamycins induces growth arrest and apoptosis in cells with HER2 overexpression via a HER3, phosphatidylinositol 3'-kinase-AKT-dependent pathway. Münster PN; Marchion DC; Basso AD; Rosen N Cancer Res; 2002 Jun; 62(11):3132-7. PubMed ID: 12036925 [TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Chen C; Shen G; Hebbar V; Hu R; Owuor ED; Kong AN Carcinogenesis; 2003 Aug; 24(8):1369-78. PubMed ID: 12819184 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models. Banerji U; Walton M; Raynaud F; Grimshaw R; Kelland L; Valenti M; Judson I; Workman P Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7023-32. PubMed ID: 16203796 [TBL] [Abstract][Full Text] [Related]
17. The heat shock protein 90 inhibitor 17-AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9. Georgakis GV; Li Y; Younes A Br J Haematol; 2006 Oct; 135(1):68-71. PubMed ID: 16925576 [TBL] [Abstract][Full Text] [Related]
18. Modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemotherapy-induced apoptosis in an RB- and schedule-dependent manner. See: E. A. Sausville, Combining cytotoxics and 17-allylamino, 17-demethoxygeldanamycin: sequence and tumor biology matters, Clin. Cancer Res., 7: 2155-2158, 2001. Münster PN; Basso A; Solit D; Norton L; Rosen N Clin Cancer Res; 2001 Aug; 7(8):2228-36. PubMed ID: 11489796 [TBL] [Abstract][Full Text] [Related]
19. Dihydroquinone ansamycins: toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives. Maroney AC; Marugan JJ; Mezzasalma TM; Barnakov AN; Garrabrant TA; Weaner LE; Jones WJ; Barnakova LA; Koblish HK; Todd MJ; Masucci JA; Deckman IC; Galemmo RA; Johnson DL Biochemistry; 2006 May; 45(17):5678-85. PubMed ID: 16634649 [TBL] [Abstract][Full Text] [Related]
20. DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair. Lin X; Trang J; Okuda T; Howell SB Clin Cancer Res; 2006 Jan; 12(2):563-8. PubMed ID: 16428501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]